Background Statins have been shown to be beneficial in primary and secondary prevention
settings; however, their role in the elderly remains a clinical conundrum, given that age …

Background Current evidence from randomized controlled trials on statins for primary
prevention of cardiovascular disease (CVD) in older people, especially those aged> 75 …

Background and aims Limited data is available on the benefit of statin for primary prevention
in the elderly. The aim of this study is to investigate whether statin for primary prevention is …

The elderly population is increasing worldwide, with subjects> 65 years of age constituting
the fastest-growing age group. Furthermore, the elderly face the greatest risk and burden of …

Purpose The use of statins in the primary prevention of cardiovascular disease (CVD) is
increasing in older adults. Nonetheless, good clinical evidence for the safety and tolerability …

Objectives The benefits of initiating statins in the elderly remains debated. We evaluated the
effects of initiating statins in the elderly, according to cardiovascular risk. Methods This …

Background Population aging is a global trend, and the elderly have a higher risk of
atherosclerotic cardiovascular disease (ASCVD) and related mortality. Statins have been …

Background: There is little consensus on using statins for primary prevention of
cardiovascular diseases (CVDs) and all-cause mortality in adults aged 75 years or older due …

Background and aims There is inadequate evidence to establish statin treatment for primary
prevention in the elderly. This study evaluated whether statins are beneficial for primary …

Background. Statin therapy significantly reduces cardiovascular events. Older patients,
however, are less likely to be prescribed statins than younger patients due to concern over …